Past and current clinical studies with GM-1 ganglioside in acute spinal cord injury
- 1 June 1993
- journal article
- clinical trial
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 22 (6) , 1041-1047
- https://doi.org/10.1016/s0196-0644(05)82748-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up dataJournal of Neurosurgery, 1992
- Recovery of Motor Function after Spinal-Cord Injury — A Randomized, Placebo-Controlled Trial with GM-1 GangliosideNew England Journal of Medicine, 1991
- National acute spinal cord injury study of methylprednisolone or naloxoneNeurosurgery, 1991
- Is Ganglioside GM1 Effective in the Treatment of Stroke?Drugs & Aging, 1991
- A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord InjuryNew England Journal of Medicine, 1990
- Functional Recovery after Decompressive Spine Operation for Cervical Spine FracturesNeurosurgery, 1987
- Gangliosides and Their Effects on Rearranging Peripheral and Central Neural PathwaysCentral Nervous System Trauma, 1984
- Biology of gangliosides: Neuritogenic and neuronotrophic propertiesJournal of Neuroscience Research, 1984
- The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegiaSpinal Cord, 1969